메뉴 건너뛰기




Volumn 110, Issue 4, 2013, Pages 697-705

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives

Author keywords

Familial investigation; Guidelines; Inherited thrombophilia; Laboratory investigation; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

EID: 84884860407     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-01-0011     Document Type: Review
Times cited : (91)

References (90)
  • 1
    • 0036799252 scopus 로고    scopus 로고
    • Screening for inherited thrombophilia: Indications and therapeutic implications
    • De Stefano V, Rossi E, Paciaroni K, et al. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002; 87: 1095-1108.
    • (2002) Haematologica , vol.87 , pp. 1095-1108
    • De Stefano, V.1    Rossi, E.2    Paciaroni, K.3
  • 2
    • 13244292326 scopus 로고    scopus 로고
    • Inherited thrombophilia and life-time risk of venous thromboem-bolism: Is the burden reducible?
    • De Stefano V. Inherited thrombophilia and life-time risk of venous thromboem-bolism: is the burden reducible? J Thromb Haemost 2004; 2: 1522-1525.
    • (2004) J Thromb Haemost , vol.2 , pp. 1522-1525
    • de Stefano, V.1
  • 3
    • 19944433631 scopus 로고    scopus 로고
    • Familial thrombophilia and life-time risk of venous thrombosis
    • Vossen C Y, Conard J, Fontcuberta J, et al. Familial thrombophilia and life-time risk of venous thrombosis. J Thromb Haemost 2004; 2: 1526-1532.
    • (2004) J Thromb Haemost , vol.2 , pp. 1526-1532
    • Vossen, C.Y.1    Conard, J.2    Fontcuberta, J.3
  • 4
    • 23944444384 scopus 로고    scopus 로고
    • Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
    • Vossen C Y, Conard J, Fontcuberta J, et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 2005; 3: 459-464.
    • (2005) J Thromb Haemost , vol.3 , pp. 459-464
    • Vossen, C.Y.1    Conard, J.2    Fontcuberta, J.3
  • 5
    • 54049096018 scopus 로고    scopus 로고
    • Does thrombophilia testing help in the clinical management of patients?
    • Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008; 143: 321-335.
    • (2008) Br J Haematol , vol.143 , pp. 321-335
    • Middeldorp, S.1    Van, H.V.A.2
  • 6
    • 70449339552 scopus 로고    scopus 로고
    • Thrombophilia: Grading the risk
    • Makris M. Thrombophilia: grading the risk. Blood 2009; 113: 5038-5039
    • (2009) Blood , vol.113 , pp. 5038-5039
    • Makris, M.1
  • 7
    • 67149089651 scopus 로고    scopus 로고
    • Selective testing for thrombophilia in patients with first venous thrombosis: Results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives
    • Lijfering WM, Brouwer JL, Veeger NJ, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009; 113: 5314-5322.
    • (2009) Blood , vol.113 , pp. 5314-5322
    • Lijfering, W.M.1    Brouwer, J.L.2    Veeger, N.J.3
  • 8
    • 0037253814 scopus 로고    scopus 로고
    • Recommendations for the first level clinical laboratories
    • European Communities Confederation of Clinical Chemistry and Laboratory Medicine, Working Group on Guidelines for Investigation of Disease. Guidelines for the laboratory investigation of inherited thrombophilias
    • Carraro P; European Communities Confederation of Clinical Chemistry and Laboratory Medicine, Working Group on Guidelines for Investigation of Disease. Guidelines for the laboratory investigation of inherited thrombophilias. Recommendations for the first level clinical laboratories. Clin Chem Lab Med 2003; 41: 382-391.
    • (2003) Clin Chem Lab Med , vol.41 , pp. 382-391
    • Carraro, P.1
  • 9
    • 33645046565 scopus 로고    scopus 로고
    • Throm-bophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence
    • European Genetics Foundation; Cardiovascular Disease Educational and Research Trust; International Union of Angiology; Mediterranean League on Thromboembolism
    • European Genetics Foundation; Cardiovascular Disease Educational and Research Trust; International Union of Angiology; Mediterranean League on Thromboembolism, Nicolaides AN, Breddin HK, Carpenter P, et al. Throm-bophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol 2005; 24: 1-26.
    • (2005) Int Angiol , vol.24 , pp. 1-26
    • Nicolaides, A.N.1    Breddin, H.K.2    Carpenter, P.3
  • 10
    • 70349866121 scopus 로고    scopus 로고
    • Italian Society for Haemostasis and Thrombosis. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    • Lussana F, Dentali F, Abbate R, et al.; Italian Society for Haemostasis and Thrombosis. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009; 124: e19-25.
    • (2009) Thromb Res , vol.124
    • Lussana, F.1    Dentali, F.2    Abbate, R.3    Et al.4
  • 11
    • 70149120091 scopus 로고    scopus 로고
    • French group on haemostasis and thrombosis; French Society of vascular medicine. Recommendations on testing for thrombophilia in venous thromboembolic disease: A French consensus guideline
    • Pernod G, Biron-Andreani C, Morange PE, et al.; French group on haemostasis and thrombosis; French Society of vascular medicine. Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc 2009; 34: 156-203.
    • (2009) J Mal Vasc , vol.34 , pp. 156-203
    • Pernod, G.1    Biron-Andreani, C.2    Morange, P.E.3
  • 12
    • 77949821581 scopus 로고    scopus 로고
    • British Committee for Standards in Haema-tology. Clinical guidelines for testing for heritable thrombophilia
    • Baglin T, Gray E, Greaves M, et al.; British Committee for Standards in Haema-tology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010; 149: 209-220.
    • (2010) Br J Haematol , vol.149 , pp. 209-220
    • Baglin, T.1    Gray, E.2    Greaves, M.3
  • 13
    • 78751633462 scopus 로고    scopus 로고
    • Recommendations from the EGAPP Working Group: Routine testing for Factor Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members
    • Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    • Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: routine testing for Factor Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med 2011;13: 67-76.
    • (2011) Genet Med , vol.13 , pp. 67-76
  • 15
    • 84856802635 scopus 로고    scopus 로고
    • American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis
    • 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Kearon C, Akl EA, Comerota AJ, et al.; American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e419S-94S.
    • (2012) Chest , vol.141 , Issue.2 SUPPL.
    • Kearon, C.1    Akl, E.A.2    Comerota, A.J.3
  • 16
    • 34047249951 scopus 로고    scopus 로고
    • Inherited thrombophilia in arterial disease: A selective review
    • de Moerloose P, Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol 2007; 44: 106-113.
    • (2007) Semin Hematol , vol.44 , pp. 106-113
    • de Moerloose, P.1    Boehlen, F.2
  • 18
    • 84867019242 scopus 로고    scopus 로고
    • Censimento 2007 delle attività delle strutture di genetica medica in Italia
    • Dallapiccola B, Agolini E, Morena A, et al. Censimento 2007 delle attività delle strutture di genetica medica in Italia. Analysis 2009; 4/5: 207-232.
    • (2009) Analysis , vol.4 , Issue.5 , pp. 207-232
    • Dallapiccola, B.1    Agolini, E.2    Morena, A.3
  • 19
    • 84867023897 scopus 로고    scopus 로고
    • Royal College of Pathologists of Australasia, Available at
    • Suthers, G. Report of the Australian Genetic Testing Survey 2006. Royal College of Pathologists of Australasia, 2009. Available at www.rcpa.edu.au/static/File/Assetlibrary/publicdocuments/MediaReleases/AustralianGeneSur-vey2006.pdf.
    • (2009) Report of the Australian Genetic Testing Survey 2006
    • Suthers, G.1
  • 20
    • 34548060279 scopus 로고    scopus 로고
    • Current practise of testing for inherited thrombophilia
    • Coppens M, van Mourik JA, Eckmann CM, et al. Current practise of testing for inherited thrombophilia. J Thromb Haemost 2007; 5: 1979-1981.
    • (2007) J Thromb Haemost , vol.5 , pp. 1979-1981
    • Coppens, M.1    van Mourik, J.A.2    Eckmann, C.M.3
  • 21
    • 70350221025 scopus 로고    scopus 로고
    • Use of Factor V Leiden genetic testing in practice and impact on management
    • Laberge AM, Psaty BM, Hindorff LA, et al. Use of Factor V Leiden genetic testing in practice and impact on management. Genet Med 2009; 11: 750-756.
    • (2009) Genet Med , vol.11 , pp. 750-756
    • Laberge, A.M.1    Psaty, B.M.2    Hindorff, L.A.3
  • 22
    • 53249107191 scopus 로고    scopus 로고
    • The emotional impact of genetic testing and aspects of counseling prior to prescription of OC
    • Gartner V, Weber M, Eichinger S. The emotional impact of genetic testing and aspects of counseling prior to prescription of OC. Contraception 2008; 78: 392-398.
    • (2008) Contraception , vol.78 , pp. 392-398
    • Gartner, V.1    Weber, M.2    Eichinger, S.3
  • 23
    • 0035912152 scopus 로고    scopus 로고
    • Genetic susceptibility to venous thrombosis
    • Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-1231.
    • (2001) N Engl J Med , vol.344 , pp. 1222-1231
    • Seligsohn, U.1    Lubetsky, A.2
  • 24
    • 0030978253 scopus 로고    scopus 로고
    • Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation
    • Ridker PM, Glynn RJ, Miletich J P, et al. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 1997; 126: 528-531.
    • (1997) Ann Intern Med , vol.126 , pp. 528-531
    • Ridker, P.M.1    Glynn, R.J.2    Miletich, J.P.3
  • 25
    • 0037307994 scopus 로고    scopus 로고
    • Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene
    • De Stefano V, Rossi E, Paciaroni K, et al. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. Haematologica 2003; 88: 61-66.
    • (2003) Haematologica , vol.88 , pp. 61-66
    • De Stefano, V.1    Rossi, E.2    Paciaroni, K.3
  • 26
    • 67249127814 scopus 로고    scopus 로고
    • RIETE Investigators. Throm-bophilia testing in patients with venous thromboembolism. Findings from the RIETE registry
    • Roldan V, Lecumberri R, Muñoz-Torrero JF, et al.; RIETE Investigators. Throm-bophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res 2009; 124: 174-177.
    • (2009) Thromb Res , vol.124 , pp. 174-177
    • Roldan, V.1    Lecumberri, R.2    Muñoz-Torrero, J.F.3
  • 27
    • 34249829228 scopus 로고    scopus 로고
    • The risk of recurrent venous throm-boembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
    • Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous throm-boembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92: 199-205.
    • (2007) Haematologica , vol.92 , pp. 199-205
    • Prandoni, P.1    Noventa, F.2    Ghirarduzzi, A.3
  • 28
    • 0342577769 scopus 로고    scopus 로고
    • Recurrent venous thromboembolism after deep vein thrombosis: Incidence and risk factors
    • Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160: 769-774.
    • (2000) Arch Intern Med , vol.160 , pp. 769-774
    • Hansson, P.O.1    Sorbo, J.2    Eriksson, H.3
  • 29
    • 0042658340 scopus 로고    scopus 로고
    • Incidence of recurrent venous throm-boembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study
    • Baglin T, Luddington R, Brown K, et al. Incidence of recurrent venous throm-boembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-526.
    • (2003) Lancet , vol.362 , pp. 523-526
    • Baglin, T.1    Luddington, R.2    Brown, K.3
  • 30
    • 18644369163 scopus 로고    scopus 로고
    • Thrombophilia, clinical factors, and recurrent venous thrombotic events
    • Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. J Am Med Assoc 2005; 293: 2352-2361.
    • (2005) J Am Med Assoc , vol.293 , pp. 2352-2361
    • Christiansen, S.C.1    Cannegieter, S.C.2    Koster, T.3
  • 31
    • 0141818976 scopus 로고    scopus 로고
    • Risk of recurrent venous thromboembolism and thrombophilia: Does discrepancy make complexity or vice versa?
    • Simioni P. Risk of recurrent venous thromboembolism and thrombophilia: does discrepancy make complexity or vice versa? J Thromb Haemost 2003; 1: 16-18.
    • (2003) J Thromb Haemost , vol.1 , pp. 16-18
    • Simioni, P.1
  • 32
    • 79959545428 scopus 로고    scopus 로고
    • Using the laboratory to predict recurrent venous thrombosis
    • Baglin T. Using the laboratory to predict recurrent venous thrombosis. Int J Lab Hematol 2011; 33: 333-342.
    • (2011) Int J Lab Hematol , vol.33 , pp. 333-342
    • Baglin, T.1
  • 33
    • 84861684787 scopus 로고    scopus 로고
    • Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: A proposed prediction score (DASH)
    • Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 2012; 10: 1019-1025.
    • (2012) J Thromb Haemost , vol.10 , pp. 1019-1025
    • Tosetto, A.1    Iorio, A.2    Marcucci, M.3
  • 34
    • 33645729527 scopus 로고    scopus 로고
    • Risk of recurrent venous thromboembol-ism in patients with common thrombophilia: A systematic review
    • Ho WK, Hankey GJ, Quinlan DJ, et al. Risk of recurrent venous thromboembol-ism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006, 166: 729-736.
    • (2006) Arch Intern Med , vol.166 , pp. 729-736
    • Ho, W.K.1    Hankey, G.J.2    Quinlan, D.J.3
  • 35
    • 35748932957 scopus 로고    scopus 로고
    • The risk of recurrent venous throm-boembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies
    • Marchiori A, Mosena L, Prins MH, et al. The risk of recurrent venous throm-boembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 2007; 92: 1107-1114.
    • (2007) Haematologica , vol.92 , pp. 1107-1114
    • Marchiori, A.1    Mosena, L.2    Prins, M.H.3
  • 36
    • 67649160484 scopus 로고    scopus 로고
    • Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: A systematic review
    • Segal JB, Brotman DJ, Necochea AJ, et al. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. J Am Med Assoc 2009; 301: 2472-2485.
    • (2009) J Am Med Assoc , vol.301 , pp. 2472-2485
    • Segal, J.B.1    Brotman, D.J.2    Necochea, A.J.3
  • 37
    • 49849088600 scopus 로고    scopus 로고
    • Testing for inherited throm-bophilia does not reduce recurrence of venous thrombosis
    • Coppens M, Reijnders JH, Middeldorp S, et al. Testing for inherited throm-bophilia does not reduce recurrence of venous thrombosis. J Thromb Haemost 2008; 6, 1474-1477.
    • (2008) J Thromb Haemost , vol.6 , pp. 1474-1477
    • Coppens, M.1    Reijnders, J.H.2    Middeldorp, S.3
  • 38
    • 84874132334 scopus 로고    scopus 로고
    • Thrombophilia testing for prevention of recurrent venous thromboembolism
    • Cohn DM, Vansenne F, de Borgie CA, et al. Thrombophilia testing for prevention of recurrent venous thromboembolism. Cochrane Database Syst Rev 2012; 12: CD007069.
    • (2012) Cochrane Database Syst Rev , vol.12
    • Cohn, D.M.1    Vansenne, F.2    de Borgie, C.A.3
  • 39
    • 0042809578 scopus 로고    scopus 로고
    • Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia
    • Palareti G, Legnani C, Cosmi B, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-318.
    • (2003) Circulation , vol.108 , pp. 313-318
    • Palareti, G.1    Legnani, C.2    Cosmi, B.3
  • 40
    • 0027465837 scopus 로고
    • Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
    • Allaart C F, Poort SR, Rosendaal FR, et al. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138.
    • (1993) Lancet , vol.341 , pp. 134-138
    • Allaart, C.F.1    Poort, S.R.2    Rosendaal, F.R.3
  • 41
    • 0023227876 scopus 로고
    • Hereditary protein S deficiency: Clinical manifestations
    • Engesser L, Broekmans AW, Briët E, et al. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-682.
    • (1987) Ann Intern Med , vol.106 , pp. 677-682
    • Engesser, L.1    Broekmans, A.W.2    Briët, E.3
  • 42
    • 0029016883 scopus 로고
    • Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
    • Zöller B, Berntsdotter A, García de Frutos P, et al. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523.
    • (1995) Blood , vol.85 , pp. 3518-3523
    • Zöller, B.1    Berntsdotter, A.2    García, D.F.P.3
  • 43
    • 33744467056 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboem-bolism in patients with inherited deficiency of natural anticoagulants anti-thrombin, protein C, and protein S
    • De Stefano V, Simioni P, Rossi E, et al. The risk of recurrent venous thromboem-bolism in patients with inherited deficiency of natural anticoagulants anti-thrombin, protein C, and protein S. Haematologica 2006; 91: 695-698.
    • (2006) Haematologica , vol.91 , pp. 695-698
    • De Stefano, V.1    Simioni, P.2    Rossi, E.3
  • 44
    • 24144492688 scopus 로고    scopus 로고
    • Recurrence rate after a first venous thrombosis in patients with familial thrombophilia
    • Vossen CY, Walker ID, Svensson P, et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol 2005; 25: 1992-1997.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 1992-1997
    • Vossen, C.Y.1    Walker, I.D.2    Svensson, P.3
  • 45
    • 60849133332 scopus 로고    scopus 로고
    • High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin
    • Brouwer JL, Lijfering WM, Ten Kate MK, et al. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost 2009; 101: 93-99.
    • (2009) Thromb Haemost , vol.101 , pp. 93-99
    • Brouwer, J.L.1    Lijfering, W.M.2    Ten, K.M.K.3
  • 46
    • 0033539096 scopus 로고    scopus 로고
    • The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
    • De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341: 801-806.
    • (1999) N Engl J Med , vol.341 , pp. 801-806
    • De Stefano, V.1    Martinelli, I.2    Mannucci, P.M.3
  • 47
    • 0032729187 scopus 로고    scopus 로고
    • Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism
    • Margaglione M, D'Andrea G, Colaizzo D, et al. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost 1999; 82: 1583-1587.
    • (1999) Thromb Haemost , vol.82 , pp. 1583-1587
    • Margaglione, M.1    D'Andrea, G.2    Colaizzo, D.3
  • 48
    • 0035865625 scopus 로고    scopus 로고
    • Risk of recurrent venous thrombosis in children with combined pro-thrombotic risk factors
    • Childhood Thrombophilia Study Group
    • Nowak-Gottl U, Junker R, Kreuz W, et al.; Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined pro-thrombotic risk factors. Blood 2001; 97: 858-862.
    • (2001) Blood , vol.97 , pp. 858-862
    • Nowak-Gottl, U.1    Junker, R.2    Kreuz, W.3
  • 49
    • 0036190724 scopus 로고    scopus 로고
    • The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders
    • Meinardi JR, Middeldorp S, de Kam PJ, et al. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders. Br J Haematol 2002; 116: 625-631.
    • (2002) Br J Haematol , vol.116 , pp. 625-631
    • Meinardi, J.R.1    Middeldorp, S.2    de Kam, P.J.3
  • 50
    • 0042833070 scopus 로고    scopus 로고
    • Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?
    • The Procare Group
    • The Procare Group. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients? Blood Coagul Fibrinolysis 2003; 14: 523-529.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 523-529
  • 51
    • 77953149536 scopus 로고    scopus 로고
    • Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review
    • Martinelli I, De Stefano V. Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review. Thromb Haemost 2010; 103: 1136-1144.
    • (2010) Thromb Haemost , vol.103 , pp. 1136-1144
    • Martinelli, I.1    de Stefano, V.2
  • 52
    • 77956639397 scopus 로고    scopus 로고
    • EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients
    • European Federation of Neurological Societies
    • Einhäupl K, Stam J, Bousser MG, et al.; European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17: 1229-1235.
    • (2010) Eur J Neurol , vol.17 , pp. 1229-1235
    • Einhäupl, K.1    Stam, J.2    Bousser, M.G.3
  • 53
    • 77953148473 scopus 로고    scopus 로고
    • Evidence and clinical judgment: Treatment of cerebral vein thrombosis
    • Ageno W, Dentali F, Squizzato A, et al. Evidence and clinical judgment: treatment of cerebral vein thrombosis. Thromb Haemost 2010; 103: 1109-1115.
    • (2010) Thromb Haemost , vol.103 , pp. 1109-1115
    • Ageno, W.1    Dentali, F.2    Squizzato, A.3
  • 54
    • 66149155797 scopus 로고    scopus 로고
    • American Association for the Study Liver Diseases Vascular disorders of the liver
    • De Leve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009; 49: 1729-1764.
    • (2009) Hepatology , vol.49 , pp. 1729-1764
    • de Leve, L.D.1    Valla, D.C.2    Garcia-Tsao, G.3
  • 55
    • 84866323353 scopus 로고    scopus 로고
    • Guidelines on the investigation and management of venous thrombosis at unusual sites
    • British Committee for Standards in Haematology
    • Tait C, Baglin T, Watson H, et al.; British Committee for Standards in Haematology. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol 2012; 159: 28-38.
    • (2012) Br J Haematol , vol.159 , pp. 28-38
    • Tait, C.1    Baglin, T.2    Watson, H.3
  • 56
    • 36049014970 scopus 로고    scopus 로고
    • Trombophilia and risk of venous thrombosis in patients with cancer
    • Decousus H, Moulin N, Quenet S, et al. Trombophilia and risk of venous thrombosis in patients with cancer. Thromb Res 2007; 120 (Suppl 2): S51-61.
    • (2007) Thromb Res , vol.120 , Issue.SUPPL. 2
    • Decousus, H.1    Moulin, N.2    Quenet, S.3    Et al.4
  • 58
    • 37549053666 scopus 로고    scopus 로고
    • Association between inherited thrombo-philic abnormalities and central venous catheter thrombosis in patients with cancer: A meta-analysis
    • Dentali F, Gianni M, Agnelli G, et al. Association between inherited thrombo-philic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis. J Thromb Haemost 2008; 6: 70-75.
    • (2008) J Thromb Haemost , vol.6 , pp. 70-75
    • Dentali, F.1    Gianni, M.2    Agnelli, G.3
  • 59
    • 33749332107 scopus 로고    scopus 로고
    • Thrombotic complications in childhood acute lymphoblastic leukemia: A meta-analysis of 17 prospective studies comprising 1752 pediatric patients
    • Caruso V, Iacoviello L, Di Castelnuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006; 108: 2216-2222.
    • (2006) Blood , vol.108 , pp. 2216-2222
    • Caruso, V.1    Iacoviello, L.2    Di, C.A.3
  • 60
    • 84873025833 scopus 로고    scopus 로고
    • International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
    • Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013; 11: 56-70.
    • (2013) J Thromb Haemost , vol.11 , pp. 56-70
    • Farge, D.1    Debourdeau, P.2    Beckers, M.3
  • 61
    • 77955709278 scopus 로고    scopus 로고
    • Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment
    • Harlev D, Zaidman I, Sarig G, et al. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. Thromb Res 2010; 126: 93-97.
    • (2010) Thromb Res , vol.126 , pp. 93-97
    • Harlev, D.1    Zaidman, I.2    Sarig, G.3
  • 62
    • 27744449206 scopus 로고    scopus 로고
    • Screening for thrombophi-lia in high-risk situations: A meta-analysis and cost-effectiveness analysis
    • Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study
    • Wu O, Robertson L, Twaddle S, et al.; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Screening for thrombophi-lia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 2005;131: 80-90.
    • (2005) Br J Haematol , vol.131 , pp. 80-90
    • Wu, O.1    Robertson, L.2    Twaddle, S.3
  • 63
    • 0029853469 scopus 로고    scopus 로고
    • Factor V Leiden: Should we screen oral contraceptive users and pregnant women?
    • Vandenbroucke J P, van der Meer FJM, Helmerhorst FM, et al. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Br Med J 1996; 313: 1127-1130.
    • (1996) Br Med J , vol.313 , pp. 1127-1130
    • Vandenbroucke, J.P.1    Van, d.M.F.J.M.2    Helmerhorst, F.M.3
  • 64
    • 0036606079 scopus 로고    scopus 로고
    • Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women
    • Clark P, Twaddle S, Walker ID, et al. Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet 2002; 359: 1919-1920.
    • (2002) Lancet , vol.359 , pp. 1919-1920
    • Clark, P.1    Twaddle, S.2    Walker, I.D.3
  • 65
    • 0035746675 scopus 로고    scopus 로고
    • American College of Medical Genetics consensus statement on factor V Leiden mutation testing
    • ACMG Factor V Leiden Working Group
    • Grody W W, Griffin JH, Taylor AK, et al.; ACMG Factor V Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 2001; 3: 139-148.
    • (2001) Genet Med , vol.3 , pp. 139-148
    • Grody, W.W.1    Griffin, J.H.2    Taylor, A.K.3
  • 66
    • 85047699672 scopus 로고    scopus 로고
    • Provision of genetic services in Europe: Current practices and issues
    • Recommendations of the European Society of Human Genetics
    • Recommendations of the European Society of Human Genetics. Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet 2003; 11 (Suppl 2): S2-S4.
    • (2003) Eur J Hum Genet , vol.11 , Issue.SUPPL. 2
  • 67
    • 1342282444 scopus 로고    scopus 로고
    • Population genetic screening programmes: Technical, social and ethical issues
    • Recommendations of the European Society of Human Genetics
    • Recommendations of the European Society of Human Genetics. Population genetic screening programmes: technical, social and ethical issues. Eur J Hum Genet 2003; 11 (Suppl 2): S5-S7
    • (2003) Eur J Hum Genet , vol.11 , Issue.SUPPL. 2
  • 68
    • 0035412353 scopus 로고    scopus 로고
    • Genetic hypercoagulability: Screening should be an informed choice
    • Green D. Genetic hypercoagulability: screening should be an informed choice. Blood 2001; 98: 20.
    • (2001) Blood , vol.98 , pp. 20
    • Green, D.1
  • 69
    • 0035412379 scopus 로고    scopus 로고
    • Genetic hypercoagulability: Prevention suggests testing family members
    • Mannucci PM. Genetic hypercoagulability: prevention suggests testing family members. Blood 2001; 98: 21-22.
    • (2001) Blood , vol.98 , pp. 21-22
    • Mannucci, P.M.1
  • 70
    • 0642311194 scopus 로고    scopus 로고
    • Pros and cons of thrombophilia testing: Pros
    • Martinelli I. Pros and cons of thrombophilia testing: pros. J Thromb Haemost 2003; 1: 410-411.
    • (2003) J Thromb Haemost , vol.1 , pp. 410-411
    • Martinelli, I.1
  • 71
    • 0642372646 scopus 로고    scopus 로고
    • Pros and cons of thrombophilia testing: Cons
    • Machin SJ. Pros and cons of thrombophilia testing: cons. J Thromb Haemost 2003; 1: 412-413.
    • (2003) J Thromb Haemost , vol.1 , pp. 412-413
    • Machin, S.J.1
  • 72
    • 1842788215 scopus 로고    scopus 로고
    • Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice
    • Bank I, Scavenius M P, Büller HR, et al. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 2004; 113: 7-12.
    • (2004) Thromb Res , vol.113 , pp. 7-12
    • Bank, I.1    Scavenius, M.P.2    Büller, H.R.3
  • 73
    • 2142646371 scopus 로고    scopus 로고
    • Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project
    • Tosetto A, Frezzato M, Rodeghiero F. Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project. J Thromb Haemost 2003; 1: 1724-1729.
    • (2003) J Thromb Haemost , vol.1 , pp. 1724-1729
    • Tosetto, A.1    Frezzato, M.2    Rodeghiero, F.3
  • 74
    • 49549085017 scopus 로고    scopus 로고
    • Family history as a risk factor for venous thromboembolism
    • EDITH Collaborative Study Group
    • Noboa S, Le Gal G, Lacut K, et al.; EDITH Collaborative Study Group. Family history as a risk factor for venous thromboembolism. Thromb Res 2008; 122: 624-629.
    • (2008) Thromb Res , vol.122 , pp. 624-629
    • Noboa, S.1    Le, G.G.2    Lacut, K.3
  • 75
    • 63849314208 scopus 로고    scopus 로고
    • The value of family history as a risk indicator for venous thrombosis
    • Bezemer ID, van der Meer FJ, Eikenboom JC, et al. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009; 169: 610-615.
    • (2009) Arch Intern Med , vol.169 , pp. 610-615
    • Bezemer, I.D.1    van der Meer, F.J.2    Eikenboom, J.C.3
  • 76
    • 78650951814 scopus 로고    scopus 로고
    • Parental history and venous thromboembolism: A nationwide study of age-specific and sex-specific familial risks in Sweden
    • Zöller B, Li X, Sundquist J, et al. Parental history and venous thromboembolism: a nationwide study of age-specific and sex-specific familial risks in Sweden. J Thromb Haemost 2011; 9: 64-70.
    • (2011) J Thromb Haemost , vol.9 , pp. 64-70
    • Zöller, B.1    Li, X.2    Sundquist, J.3
  • 77
    • 79251558446 scopus 로고    scopus 로고
    • Familial risk of venous thromboembolism: A nationwide cohort study
    • Sørensen HT, Riis AH, Diaz LJ, et al. Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost 2011; 9: 320-324.
    • (2011) J Thromb Haemost , vol.9 , pp. 320-324
    • Sørensen, H.T.1    Riis, A.H.2    Diaz, L.J.3
  • 78
    • 84874769997 scopus 로고    scopus 로고
    • Familial risk of venous thromboembolism in first-, second and third-degree relatives: A nationwide family study in Sweden
    • Zöller B, Ohlsson H, Sundquist J, et al. Familial risk of venous thromboembolism in first-, second and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost 2013; 109: 458-463.
    • (2013) Thromb Haemost , vol.109 , pp. 458-463
    • Zöller, B.1    Ohlsson, H.2    Sundquist, J.3
  • 79
    • 0034126578 scopus 로고    scopus 로고
    • Venous thrombotic risk in family members of unselected individuals with factor V Leiden
    • Lensen RP, Bertina RM, de Ronde H, et al. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost 2000; 83: 817-821.
    • (2000) Thromb Haemost , vol.83 , pp. 817-821
    • Lensen, R.P.1    Bertina, R.M.2    de Ronde, H.3
  • 80
    • 80053213805 scopus 로고    scopus 로고
    • In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband
    • Rossi E, Ciminello A, Za T, et al. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband. Thromb Haemost 2011; 106: 646-654.
    • (2011) Thromb Haemost , vol.106 , pp. 646-654
    • Rossi, E.1    Ciminello, A.2    Za, T.3
  • 81
    • 35548956390 scopus 로고    scopus 로고
    • Antithrombotic therapy and pregnancy: Consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes
    • Pregnancy and Thrombosis Working Group
    • Duhl AJ, Paidas MJ, Ural SH, et al.; Pregnancy and Thrombosis Working Group. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007; 197: 457.e1-21.
    • (2007) Am J Obstet Gynecol , vol.197 , Issue.457
    • Duhl, A.J.1    Paidas, M.J.2    Ural, S.H.3
  • 84
    • 84856842729 scopus 로고    scopus 로고
    • Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 124: Inherited thrombophilias in pregnancy
    • Lockwood C, Wendel G; Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstet Gynecol 2011; 118: 730-740.
    • (2011) Obstet Gynecol , vol.118 , pp. 730-740
    • Lockwood, C.1    Wendel, G.2
  • 85
    • 84856809942 scopus 로고    scopus 로고
    • American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis
    • 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Bates SM, Greer IA, Middeldorp S, et al.; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e691S-736S.
    • (2012) Chest , vol.141 , Issue.2 SUPPL.
    • Bates, S.M.1    Greer, I.A.2    Middeldorp, S.3
  • 86
    • 84856970795 scopus 로고    scopus 로고
    • Councils of the Society of Obstetric Medicine of Australia and New Zealand; Australasian Society of Thrombosis and Haemostasis. Recommendations for the prevention of pregnancy-associated venous thromboembolism
    • McLintock C, Brighton T, Chunilal S, et al.; Councils of the Society of Obstetric Medicine of Australia and New Zealand; Australasian Society of Thrombosis and Haemostasis. Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol 2012; 52: 3-13.
    • (2012) Aust N Z J Obstet Gynaecol , vol.52 , pp. 3-13
    • McLintock, C.1    Brighton, T.2    Chunilal, S.3
  • 87
    • 84884890847 scopus 로고    scopus 로고
    • Royal College of Obstetricians and Gynaecologists, Green-top Guideline No, Available at
    • Royal College of Obstetricians and Gynaecologists. Venous thromboembolism and hormonal contraception. Green-top Guideline No. 40, 2010. Available at www.rcog.org.uk.
    • (2010) Venous Thromboembolism and Hormonal Contraception , pp. 40
  • 88
    • 84926511726 scopus 로고    scopus 로고
    • Royal College of Obstetricians and Gynaecologists, Green-top Guideline No, Available at
    • Royal College of Obstetricians and Gynaecologists. Venous thromboembolism and hormone replacement therapy. Green-top Guideline No. 11, 2011. Available at www.rcog.org.uk.
    • (2011) Venous Thromboembolism and Hormone Replacement Therapy , pp. 11
  • 89
    • 72949116790 scopus 로고    scopus 로고
    • Systematic review: Family history in risk assessment for common diseases
    • Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: family history in risk assessment for common diseases. Ann Intern Med 2009; 151: 878-885.
    • (2009) Ann Intern Med , vol.151 , pp. 878-885
    • Wilson, B.J.1    Qureshi, N.2    Santaguida, P.3
  • 90
    • 34047133773 scopus 로고    scopus 로고
    • Evidence-based medicine for rare diseases: Implications for data interpretation and clinical trial design
    • Behera M, Kumar A, Soares HP, et al. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design. Cancer Control 2007; 14: 160-166.
    • (2007) Cancer Control , vol.14 , pp. 160-166
    • Behera, M.1    Kumar, A.2    Soares, H.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.